Ryszard Smolarczyk

1.8k total citations · 1 hit paper
48 papers, 1.4k citations indexed

About

Ryszard Smolarczyk is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Ryszard Smolarczyk has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 20 papers in Immunology and 12 papers in Oncology. Recurrent topics in Ryszard Smolarczyk's work include Immune cells in cancer (9 papers), Mesenchymal stem cell research (7 papers) and Immunotherapy and Immune Responses (6 papers). Ryszard Smolarczyk is often cited by papers focused on Immune cells in cancer (9 papers), Mesenchymal stem cell research (7 papers) and Immunotherapy and Immune Responses (6 papers). Ryszard Smolarczyk collaborates with scholars based in Poland, France and Czechia. Ryszard Smolarczyk's co-authors include Tomasz Cichoń, Magdalena Jarosz–Biej, Stanisław Szala, Justyna Czapla, Sybilla Matuszczak, Aleksander Sochanik, Halina Waś, Alicja Józkowicz, Józef Dulak and Anna Grochot‐Przeczek and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Ryszard Smolarczyk

46 papers receiving 1.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy

2019 378 citations Magdalena Jarosz–Biej, Ryszard Smolarczyk et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryszard Smolarczyk Poland	18	647	373	340	214	198	48	1.4k
Tomasz Cichoń Poland	19	698 1.1×	378 1.0×	348 1.0×	221 1.0×	209 1.1×	58	1.4k
Yan Fan China	20	695 1.1×	453 1.2×	353 1.0×	304 1.4×	131 0.7×	67	1.5k
Yihui Shi United States	21	841 1.3×	493 1.3×	276 0.8×	386 1.8×	182 0.9×	50	1.8k
Tao Fang China	25	1.0k 1.6×	457 1.2×	308 0.9×	446 2.1×	286 1.4×	53	1.8k
Sang‐Yeob Kim South Korea	24	797 1.2×	440 1.2×	271 0.8×	262 1.2×	266 1.3×	81	1.6k
Sanam Sadreddini Iran	16	734 1.1×	281 0.8×	265 0.8×	366 1.7×	138 0.7×	25	1.4k
Laëtitia Delort France	24	627 1.0×	470 1.3×	148 0.4×	300 1.4×	239 1.2×	45	1.6k
Yao Yuan China	20	855 1.3×	500 1.3×	174 0.5×	376 1.8×	170 0.9×	72	1.6k
Akimasa Seno Japan	19	658 1.0×	563 1.5×	175 0.5×	203 0.9×	177 0.9×	64	1.1k
Yuhua Li China	24	861 1.3×	641 1.7×	244 0.7×	367 1.7×	159 0.8×	88	1.7k

Countries citing papers authored by Ryszard Smolarczyk

Since Specialization

Citations

This map shows the geographic impact of Ryszard Smolarczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryszard Smolarczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryszard Smolarczyk more than expected).

Fields of papers citing papers by Ryszard Smolarczyk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryszard Smolarczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryszard Smolarczyk. The network helps show where Ryszard Smolarczyk may publish in the future.

Co-authorship network of co-authors of Ryszard Smolarczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Ryszard Smolarczyk. A scholar is included among the top collaborators of Ryszard Smolarczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryszard Smolarczyk. Ryszard Smolarczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smolarczyk, Ryszard, Monika Musiał‐Kulik, Sybilla Matuszczak, et al.. (2025). Comparison of Micelles Single- and Dual-Targeted with Folic Acid and Biotin as the Delivery System of Docetaxel─The Influence of the Type and Amount of the Ligand on Morphology, Physicochemical Properties, and Cytotoxicity. Molecular Pharmaceutics. 22(8). 4662–4678.

Czapla, Justyna, et al.. (2025). Differential Response to Local Stimulator of Interferon Genes Agonist Administration in Tumors with Various Stimulator of Interferon Genes Statuses. Cancers. 17(2). 175–175.

Czapla, Justyna, Ryszard Smolarczyk, Sybilla Matuszczak, et al.. (2024). The comparison of adipose-derived stromal cells (ADSCs) delivery method in a murine model of hindlimb ischemia. Stem Cell Research & Therapy. 15(1). 27–27. 1 indexed citations

Czapla, Justyna, Sybilla Matuszczak, Tomasz Cichoń, et al.. (2023). Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context. Frontiers in Oncology. 13. 1249524–1249524. 11 indexed citations

Matuszczak, Sybilla, et al.. (2023). The Effect of Radiotherapy on Cell Survival and Inflammatory Cytokine and Chemokine Secretion in a Co-Culture Model of Head and Neck Squamous Cell Carcinoma and Normal Cells. Biomedicines. 11(6). 1773–1773. 2 indexed citations

Biesaga, Beata, Ryszard Smolarczyk, Anna Mucha-Małecka, et al.. (2022). Prognostic Significance of STING Immunoexpression in Relation to HPV16 Infection in Patients with Squamous Cell Carcinomas of Oral Cavity and Oropharynx. Biomedicines. 10(10). 2538–2538. 6 indexed citations

Czapla, Justyna, et al.. (2022). The Complex Composition of Trans-resveratrol, Quercetin, Vitamin E and Selenium Inhibits the Growth of Colorectal Carcinoma. Anticancer Research. 42(10). 4763–4772. 4 indexed citations

Hrdinka, Matouš, Ryszard Smolarczyk, Tomasz Cichoń, et al.. (2021). Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment. Cells. 10(5). 967–967. 12 indexed citations

Cichoń, Tomasz, Justyna Czapla, Magdalena Jarosz–Biej, et al.. (2021). The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent—DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors. Cancers. 13(16). 3924–3924. 13 indexed citations

10.

Cichoń, Tomasz, Justyna Czapla, Magdalena Jarosz–Biej, et al.. (2021). Mesenchymal stromal cells as carriers of IL-12 reduce primary and metastatic tumors of murine melanoma. Scientific Reports. 11(1). 18335–18335. 19 indexed citations

11.

Jaworska, Joanna, Ryszard Smolarczyk, Monika Musiał‐Kulik, et al.. (2021). Electrospun paclitaxel delivery system based on PGCL/PLGA in local therapy combined with brachytherapy. International Journal of Pharmaceutics. 602. 120596–120596. 16 indexed citations

12.

Jarosz–Biej, Magdalena, Ryszard Smolarczyk, Tomasz Cichoń, et al.. (2020). Brachytherapy in a Single Dose of 10Gy as an “in situ” Vaccination. International Journal of Molecular Sciences. 21(13). 4585–4585. 14 indexed citations

13.

Waś, Halina, Tomasz Cichoń, Ryszard Smolarczyk, et al.. (2020). Effect of Heme Oxygenase-1 on Melanoma Development in Mice—Role of Tumor-Infiltrating Immune Cells. Antioxidants. 9(12). 1223–1223. 12 indexed citations

14.

Czapla, Justyna, Tomasz Cichoń, Magdalena Jarosz–Biej, et al.. (2020). Adipose tissue-derived stromal cells stimulated macrophages-endothelial cells interactions promote effective ischemic muscle neovascularization. European Journal of Pharmacology. 883. 173354–173354. 8 indexed citations

15.

Jarosz–Biej, Magdalena, et al.. (2019). Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy. International Journal of Molecular Sciences. 20(13). 3212–3212. 378 indexed citations breakdown →

16.

Vydra, Natalia, et al.. (2019). PHLDA1 Does Not Contribute Directly to Heat Shock-Induced Apoptosis of Spermatocytes. International Journal of Molecular Sciences. 21(1). 267–267. 3 indexed citations

17.

Jarosz–Biej, Magdalena, Sybilla Matuszczak, Tomasz Cichoń, et al.. (2018). M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma. PLoS ONE. 13(1). e0191012–e0191012. 64 indexed citations

18.

Jelonek, Katarzyna, Janusz Kasperczyk, Suming Li, et al.. (2018). Bioresorbable filomicelles for targeted delivery of betulin derivative – In vitro study. International Journal of Pharmaceutics. 557. 43–52. 21 indexed citations

19.

Jarosz–Biej, Magdalena, Ryszard Smolarczyk, Tomasz Cichoń, et al.. (2015). Combined Tumor Cell-Based Vaccination and Interleukin-12 Gene Therapy Polarizes the Tumor Microenvironment in Mice. Archivum Immunologiae et Therapiae Experimentalis. 63(6). 451–464. 11 indexed citations

20.

Smolarczyk, Ryszard, Tomasz Cichoń, & Stanisław Szala. (2009). [Peptides: a new class of anticancer drugs].. PubMed. 63. 360–8. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact